[HDL ‐C/apoA‐I]: A multivessel cardiometabolic risk marker in women with T2DM

Conclusion[HDL‐C/apoA‐I] can stratify T2DM women according to metabolic phenotype, macrovascular and coronary damage, β‐cell function, microangiopathic risk, and retinopathy. This ratio is a versatile and readily available marker of cardiometabolic status and vascular complications in T2DM women.

Source: Diabetes/Metabolism Research and Reviews - October 16, 2017 Category: Endocrinology Authors: Michel P. Hermans, Paul Valensi, Sylvie A. Ahn, Michel F. Rousseau Tags: RESEARCH ARTICLE Source Type: research